# Triad Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/triad-therapeutics

- Industry: Biotechnology
- Headquarters: San Diego, US
- Total disclosed funding: $30M
- Latest round: Series B (Jan 1, 2001)
- Investors on record: 9

## About

Triad Therapeutics, Inc. headquarter in San Diego, US and develops targeted drug candidates through NMR spectroscopy guided techniques.

## Funding rounds

- Series B, Jan 1, 2001, $30M — Mediphase Venture Partners, Skyline Ventures, Johnson & Johnson Innovation, Credit Suisse Pension Fund, GeneChem, Invus [DUP], Tekla Capital Management, Lombard Odier Asset Management, International Biomedicine Holdings

## Investors

- Mediphase Venture Partners (https://capitalatlas.ai/funds/mediphase-venture-partners) — Series B
- Skyline Ventures (https://capitalatlas.ai/funds/skyline-ventures) — Series B
- Johnson & Johnson Innovation (https://capitalatlas.ai/funds/johnson-johnson-innovation) — Series B
- Credit Suisse Pension Fund — Series B
- GeneChem (https://capitalatlas.ai/funds/genechem) — Series B
- Invus [DUP] — Series B
- Tekla Capital Management (https://capitalatlas.ai/funds/tekla-capital-management) — Series B
- Lombard Odier Asset Management — Series B
- International Biomedicine Holdings — Series B